|
3-Methylthio-1,4-diphenyl-1H-1,3,4-triazolium |
|
Escherichia |
Heat-labile toxin (LT) |
Preclinical (in vivo) |
Hovey BT, et al. 1999. J Mol Biol |
|
Ellipticine hydrochloride |
Depiction based on curated SMILES
ClH
CH
3
N
H
CH
3
N
|
Streptococcus |
Suilysin |
Preclinical (in vivo) |
Wang C, et al. 2021. Appl Environ Microbiol |
|
N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-4-(1,3-oxazol-5-yl)benzamide |
Depiction based on curated SMILES
HO
N
N
+
N
O
_
O
N
H
O
O
N
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Garrity-Ryan LK, et al. 2010. Infect Immun |
|
(4-chloro-2-methyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-3-yl)methyl imidothiocarbamate |
Depiction based on curated SMILES
H
2
N
NH
S
Cl
H
3
C
N
O
N
|
Helicobacter |
Flagella |
Preclinical (in vivo) |
Suerbaum S, et al. 2022. mBio |
|
Ethoxzolamide |
Depiction based on curated SMILES
CH
3
O
N
S
S
O
O
NH
2
|
Mycobacterium |
Regulation |
Preclinical (in vivo) |
Johnson BK, et al. 2015. Antimicrob Agents Chemother |
|
6-(2-chlorophenyl)-3-(4-pyridinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole |
Depiction based on curated SMILES
N
Cl
N
S
N
N
N
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Zhang J, et al. 2014. Proc Natl Acad Sci U S A |
|
6-(3H-benzimidazol-5-yl)-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole |
Depiction based on curated SMILES
N
N
N
N
HN
S
N
N
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Zhang J, et al. 2014. Proc Natl Acad Sci U S A |
|
Sodium 3-(3-(pyridin-4-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)benzenesulfonate |
Depiction based on curated SMILES
N
S
N
N
N
O
N
+
Na
_
O
O
S
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Zhang J, et al. 2014. Proc Natl Acad Sci U S A |
|
(5R,6R)-5,6-bis[(4-benzyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
H
N
H
2
N
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-butyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
N
N
H
2
N
N
H
N
N
H
3
C
N
H
3
C
H
H
N
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
| | |